Sickle Cell Disease Market Set for Robust Expansion at a CAGR of 22.1% (2026–2034) Across 6MM, Driven by Rising Prevalence and Breakthrough Gene Therapies | DelveInsight
The Sickle Cell Disease (SCD) market is projected to experience remarkable growth through 2034, supported by increasing disease prevalence, improving diagnostic awareness, and rapid advancements in disease-modifying and gene-based therapies. According to DelveInsight, the market is expected to expand at a CAGR
